Tag Archives: Wegovy

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding to the list of conditions for which the blockbuster therapy is now approved.  The Food and Drug Administration granted accelerated approval to Wegovy for patients with metabolic dysfunction-associated steatohepatitis, or MASH, with moderate to advanced liver scarring. The decision was …

Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance Novo Nordisk’s Wegovy Gets US Approval for …

Novo Nordisk’s Wegovy Gets US Approval for Liver Disease  Bloomberg.com Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance Novo Nordisk’s Wegovy gets accelerated US approval for liver …

Quit Ozempic or Wegovy? Here’s How Fast the Pounds Can Come Back  SciTechDailyView Full Coverage on Google News Source link

Could This Tiny Molecule Be Better Than Ozempic and Wegovy for Obesity?  SciTechDaily Scientists just found a tiny molecule that could change how we lose weight  ScienceDaily Researchers Identify Microproteins as Potential Tools for Addressing Obesity Affecting Over One Billion Worldwide  geneonline.com Hidden Proteins in Fat May Unlock Obesity Cure  ScienceBlog.com Discovering Microproteins as Novel Therapies for Obesity and Metabolic Disorders  BIOENGINEER.ORG Source link

Novo Nordisk lowered its sales forecast for obesity drug Wegovy, citing competition from compounded versions. Scott Olson/Getty Images hide caption toggle caption Scott Olson/Getty Images Novo Nordisk’s shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity medicine, Wegovy, are expected …

Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker Has New CEO, Cuts U.S. Outlook  Barron’s Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Novo Promotes Insider to CEO After Weight-Loss Drug Slowdown  Bloomberg Europe shares dented as Novo warning burns $92 bln in market cap  Reuters Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO  Yahoo Finance Source link

Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic  MarketWatch Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook  Yahoo Finance Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short  Bloomberg Novo Nordisk Stock Plummets After Ozempic, Wegovy Maker Cuts U.S. Outlook  Barron’s Source link

The Patients Forced to Switch From Zepbound to Wegovy  The Wall Street Journal Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage  foxnews.com A Value-Based Price for Anti-Obesity Medications  USC Schaeffer Weight-loss drugs too costly for Arizona Medicaid patients, until obesity leads to diabetes  Tucson Sentinel How to find out if weight loss drugs are covered by your insurance, and …

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know …